US 6329349
Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
expired A61KA61K45/06
Quick answer
US patent 6329349 (Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K45/06